Glial Fibrillary Acidic Protein – Apolipoprotein E ( apoE ) Transgenic Mice : Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE 3 and apoE 4 Lipoproteins
暂无分享,去创建一个
Guojun Bu | Yuling Sun | David M. Holtzman | Anne M. Fagan | A. Fagan | D. Holtzman | G. Bu | M. LaDu | Shan Wu | Moyosore K. Onifade | Shilen N. Patel | Mary Jo LaDu | Yuling Sun | Shan Wu
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] D. Holtzman,et al. Nascent Astrocyte Particles Differ from Lipoproteins in CSF , 1998, Journal of neurochemistry.
[3] A. Roses. Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain , 1997, Neurobiology of Disease.
[4] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.
[5] G. Murray,et al. Association of apolipoprotein E polymorphism with outcome after head injury , 1997, The Lancet.
[6] G. Schellenberg,et al. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes , 1997, Annals of neurology.
[7] W. White,et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. , 1997, The Annals of thoracic surgery.
[8] W. Strittmatter,et al. Apolipoprotein E Binds to and Potentiates the Biological Activity of Ciliary Neurotrophic Factor , 1997, The Journal of Neuroscience.
[9] D. Michaelson,et al. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury , 1997, Neuroscience.
[10] N. Maeda,et al. Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.
[11] M. Mattson,et al. Isoform‐Specific Modulation by Apolipoprotein E of the Activities of Secreted β‐Amyloid Precursor Protein , 1997, Journal of neurochemistry.
[12] A. Roses,et al. Apolipoprotein E-Deficient Mice Have Increased Susceptibility To Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] A. Fagan,et al. Endogenous FGF-2 Is Important for Cholinergic Sprouting in the Denervated Hippocampus , 1997, The Journal of Neuroscience.
[14] A. Hofman,et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. , 1997, JAMA.
[15] S. Vandenberg,et al. Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture , 1997, Brain Research.
[16] D. Holtzman,et al. The Low‐Density Lipoprotein Receptor‐Related Protein, a Multifunctional Apolipoprotein E Receptor, Modulates Hippocampal Neurite Development , 1997, Journal of neurochemistry.
[17] T. Morgan,et al. Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNAin Vivoandin Vitro , 1997, Experimental Neurology.
[18] B. Hyman,et al. Amyloid β-Peptide Is Transported on Lipoproteins and Albumin in Human Plasma* , 1996, The Journal of Biological Chemistry.
[19] A. Fagan,et al. Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.
[20] J. Hixson,et al. Human APOE protein localized in brains of transgenic mice , 1996, Neuroscience Letters.
[21] R. Mahley,et al. Human apolipoprotein E: the Alzheimer's disease connection , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.
[23] R. Beavis,et al. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. , 1996, Biochemical and biophysical research communications.
[24] M. Nakai,et al. Expression of apolipoprotein E mRNA in rat microglia , 1996, Neuroscience Letters.
[25] J. Gilbert,et al. Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.
[26] K. Goto,et al. Human Apolipoprotein E Receptor 2 , 1996, The Journal of Biological Chemistry.
[27] B. Hyman,et al. Expression of the Very Low‐Density Lipoprotein Receptor (VLDL‐r), an Apolipoprotein‐E Receptor, in the Central Nervous System and in Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[28] D. Herbert,et al. Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Fages,et al. Apolipoprotein E gene expression in astrocytes: developmental pattern and regulation , 1995, Neuroreport.
[30] R. Mahley,et al. Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.
[31] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] W. Strittmatter,et al. ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.
[33] E Brisch,et al. The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.
[34] C. Wernstedt,et al. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain , 1995, Neuron.
[35] G. Getz,et al. Purification of Apolipoprotein E Attenuates Isoform-specific Binding to -Amyloid (*) , 1995, The Journal of Biological Chemistry.
[36] R. James,et al. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. , 1995, Biochimica et biophysica acta.
[37] N. Lenn,et al. TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] P. Lansbury,et al. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] F. Maxfield,et al. Effects of Apoprotein E on Intracellular Metabolism of Model Triglyceride-rich Particles Are Distinct from Effects on Cell Particle Uptake (*) , 1995, The Journal of Biological Chemistry.
[40] M. Pericak-Vance,et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] G. Getz,et al. Isoform-specific binding of apolipoprotein E to beta-amyloid. , 1994, The Journal of biological chemistry.
[42] D. Strickland,et al. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. , 1994, The Journal of biological chemistry.
[43] D. Selkoe,et al. Alzheimer's Disease: A Central Role for Amyloid , 1994, Journal of neuropathology and experimental neurology.
[44] J. Nerbonne,et al. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. , 1994, The Journal of biological chemistry.
[45] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[46] M. Mattson. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. , 1994, Journal of neurobiology.
[47] A. Messing,et al. GFAP promoter directs astrocyte-specific expression in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] A. Fagan,et al. Mechanisms of sprouting in the adult central nervous system: Cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus , 1994, Neuroscience.
[49] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[50] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[51] S. Gauthier,et al. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats , 1993, Neuroscience.
[52] A. Schwartz,et al. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. , 1993, The Journal of biological chemistry.
[53] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] G. Handelmann,et al. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. , 1992, Journal of lipid research.
[55] S. Vandenberg,et al. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. , 1992, The American journal of pathology.
[56] N. Maeda,et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[57] Thomas Wisniewski,et al. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.
[58] D. Holtzman,et al. Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. , 1992, The EMBO journal.
[59] M. Brown,et al. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1991, The Journal of biological chemistry.
[60] C. Finch,et al. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. , 1991, Brain research. Molecular brain research.
[61] D. Strickland,et al. Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. , 1991, The Journal of biological chemistry.
[62] S. Young,et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. , 1991, The Journal of clinical investigation.
[63] R. Mahley,et al. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. , 1990, The Journal of biological chemistry.
[64] S. Prusiner,et al. Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[66] R. Mahley,et al. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.
[67] P. Coleman,et al. Failed Compensatory Dendritic Growth as a Pathophysiological Process in Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[68] J. Taylor,et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.
[69] G. Vega,et al. Apolipoproteins in human cerebrospinal fluid. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[70] D. Graham,et al. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. , 1995, Nature medicine.
[71] S. Wilton,et al. Apolipoprotein E and Alzheimer's disease , 1995 .
[72] J. Ma,et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. , 1994, Nature.
[73] M. Krieger,et al. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.
[74] D. Choi,et al. 4 – Cytotoxicity in Murine Neocortical Cell Culture , 1993 .
[75] J. Polonovski,et al. [Human apolipoprotein E: polymorphism and binding domain of the receptors]. , 1986, Biochimie.